Brilliant Board Review – Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS)

Details

This complimentary CME course offers a focused review of DKA and HHS, emphasizing critical management strategies, including intravenous fluid administration and insulin therapy. Designed for healthcare professionals, the course aims to enhance clinical decision-making skills in acute diabetic emergencies.

Topics Covered

• Review CME Information
• Video Lesson
• Post-Test
• Evaluation
• Claim Certificate

Learning Objectives

• Differentiate Between DKA and HHS – Accurately distinguish between Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS) based on clinical presentation, laboratory findings, and pathophysiology.
• Implement Evidence-Based Treatment Strategies – Apply appropriate fluid resuscitation, electrolyte replacement, and insulin therapy based on current guidelines to improve patient outcomes.
• Recognize and Prevent Common Complications – Identify life-threatening complications such as hypokalemia, cerebral edema, and thrombosis, ensuring timely intervention and prevention.
• Manage Euglycemic DKA and Special Populations – Understand how SGLT2 inhibitors contribute to euglycemic DKA and modify treatment approaches for pediatric, elderly, and critically ill patients.
• Enhance Patient Education and Long-Term Care – Provide comprehensive discharge planning and diabetes education to prevent recurrent hospitalizations and improve long-term diabetes management.

Target Audience

Physicians (MDs, DOs), Residents, Interns and other health care professionals.

Additional credit info

• Eligibility: Participants scoring 70% or higher on the post-test and completing the course evaluation form.

• Credit Type: AMA PRA Category 1 Credit™

• Credit Hours: One